Oxidative stress markers are not valuable markers in lean and early age of polycystic ovary syndrome patients

被引:0
作者
E. Cakir
M. Ozbek
E. Ozkaya
N. Colak
E. Cakal
M. Sayki
A. Gungunes
Y. Aliyazicioglu
A. Mentese
T. Delibasi
机构
[1] Diskapi Yildirim Beyazit Training and Research Hospital,Department of Endocrinology and Metabolism
[2] Sami Ulus Maternity and Women’s Health Training and Research Hospital,Department of Obstetrics and Gynecology
[3] Karadeniz Technical University,Division of Biochemistry
[4] Faculty of Medicine,undefined
来源
Journal of Endocrinological Investigation | 2011年 / 34卷
关键词
Inflammation; oxidative stress; polycystic ovary syndrome;
D O I
暂无
中图分类号
学科分类号
摘要
Background: Early atherosclerosis and increased risk of cardiovascular diseases (CVD) have been reported in patients with polycystic ovary syndrome (PCOS). Oxidative stress is an accepted risk factor for the development of CVD. Aim: To evaluate the association between oxidative stress markers [ischemia-modified albumin (IMA), total antioxidant status (TAS), and total oxidant status (TOS) levels], carotid intima-media thickness (CIMT), endocrine and metabolic parameters in patients with PCOS. Materials, subjects, and methods: We studied 52 patients with PCOS and 36 age- and body mass index (BMI)-matched controls. The diagnosis of PCOS was made according to the Rotterdam criteria. Metabolic, hormonal parameter and IMA, TAS, TOS levels were measured. Results: No statistically significant difference was determined in relation to age, BMI and waist-hip ratio, IMA, TAS, and TOS levels between groups. Mean IMA level was higher in PCOS patients, however, statistical significant difference was not observed. Mean CIMT and homeostasis model assessment of insulin resistance levels were significantly higher in patients with PCOS than in control subjects. Conclusion: Our study has shown that although CIMT levels, showing CVD risk, were higher in PCOS patients, TAS and TOS oxidative stress markers were found to be similar between groups, IMA was higher in PCOS patients however the difference was not reach statistical significant. The present results suggest that CIMT increases before the state of ischemia and shows preischemic state of vasculature, while oxidative stress markers are considered to be indicators of ischemia and reperfusion injury in progressive vascular disease. Further studies are needed to show the association between oxidative stress markers, CVD and PCOS.
引用
收藏
页码:e178 / e182
相关论文
共 148 条
[1]  
Tang T(2009)Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility Cochrane Database Syst Rev 13 CD003053-59
[2]  
Lord JM(2006)The impact of obesity on reproduction in women with polycystic ovary syndrome BJOG 113 1148-701
[3]  
Norman RJ(2004)The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study J Clin Endocrinol Metab 89 3696-5
[4]  
Yasmin E(2001)Low grade chronic inflammation in women with polycystic ovarian syndrome J Clin Endocrinol Metab 86 2453-6
[5]  
Balen AH(2002)Altered vascular function in young women with polycystic ovary syndrome J Clin Endocrinol Metab 87 742-82
[6]  
Pasquali R(2005)The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome Endocr Rev 26 251-13
[7]  
Gambineri A(2001)Oxidative stress in poycystic ovary syndrome and its contribution to the risk of cardiovascular disease Clin Biochem 34 407-12
[8]  
Pagotto U(2003)Polycystic ovary syndrome and cardiovascular disease: a premature association Endocrinol Rev 24 302-8
[9]  
Orio F(2000)What is the oxidative stress? Metabolism 49 13-67
[10]  
Palomba S(1996)Oxidative stres and diabetic vascular complications Diabetes Care 19 257-8